Skip to main content
Top
Published in: Advances in Therapy 4/2015

Open Access 01-04-2015 | Original Research

Patient Reported Burden of Asthma on Resource Use and Productivity Across 11 Countries in Europe

Authors: Monica Fletcher, Ashok Jha, William Dunlop, Louise Heron, Verena Wolfram, Thys Van der Molen, David Price

Published in: Advances in Therapy | Issue 4/2015

Login to get access

Abstract

Introduction

Asthma affects 30 million people in Western Europe, leading to substantial burden on healthcare systems and economies. REcognise Asthma and LInk to Symptoms and Experience (REALISE™) was a large European survey across 11 countries assessing patient attitudes and behaviors towards their asthma. The present study utilizes REALISE™ data to understand resource use and absenteeism in asthma.

Methods

Data were collected on absenteeism and healthcare resource use from 8000 asthma patients (aged 18–50 years) across the 11 countries. All data were patient reported. Odds ratios (ORs) were calculated against the country with the lowest proportion of respondents for hospitalization (as a proxy for lowest resource use).

Results

Patient characteristics were broadly similar across countries. However, self-reported asthma control status varied. More than 50% of respondents in most countries considered primary healthcare professionals (HCPs), i.e., general practitioners and nurses, the main HCP they see about their asthma. However, in some countries, specialists or nurses were considered the main HCP. Hospitalization was lowest amongst patients in the Netherlands. Resource use and productivity loss varied widely across the countries; ORs for hospitalization ranged from 1 in Sweden to 4 in Norway and for productivity loss from 0.6 in Sweden to 2.6 in Italy, compared with the Netherlands.

Conclusion

This study quantified utilization of healthcare resources in asthma (number of visits of HCPs, hospitalization, and accident and emergency visits) as well as absenteeism and showed that differences exist across countries. The differences in primary care and specialist use suggest a possible difference in healthcare delivery across countries.

Funding

Mundipharma International Limited, Cambridge, UK.
Appendix
Available only for authorised users
Literature
2.
go back to reference Doz M, Chouaid C, Com-Ruelle L, et al. The association between asthma control, health care costs, and quality of life in France and Spain. BMC Pulm Med. 2013;13:15.CrossRefPubMedCentralPubMed Doz M, Chouaid C, Com-Ruelle L, et al. The association between asthma control, health care costs, and quality of life in France and Spain. BMC Pulm Med. 2013;13:15.CrossRefPubMedCentralPubMed
3.
go back to reference Vervloet D, Williams A, Lloyd A, Clark T. Costs of managing asthma as defined by a derived Asthma Control TestTM score in seven European countries. Eur Respir Rev. 2006;15(98):17–23.CrossRef Vervloet D, Williams A, Lloyd A, Clark T. Costs of managing asthma as defined by a derived Asthma Control TestTM score in seven European countries. Eur Respir Rev. 2006;15(98):17–23.CrossRef
5.
go back to reference Demoly P, Annunziata K, Gubba E, Adamek L. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev. 2012;21(123):66–74.CrossRefPubMed Demoly P, Annunziata K, Gubba E, Adamek L. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev. 2012;21(123):66–74.CrossRefPubMed
6.
go back to reference Dal Negro RW, Micheletto C, Tosatto R, Dionisi M, Turco P, Donner CF. Costs of asthma in Italy: results of the SIRIO (Social Impact of Respiratory Integrated Outcomes) study. Respir Med. 2007;101(12):2511–9.CrossRefPubMed Dal Negro RW, Micheletto C, Tosatto R, Dionisi M, Turco P, Donner CF. Costs of asthma in Italy: results of the SIRIO (Social Impact of Respiratory Integrated Outcomes) study. Respir Med. 2007;101(12):2511–9.CrossRefPubMed
7.
go back to reference Asthma GIf. GINA Report, Global strategy for asthma management and prevention, 2012. 2014. Asthma GIf. GINA Report, Global strategy for asthma management and prevention, 2012. 2014.
8.
go back to reference Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24:14009.PubMed Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24:14009.PubMed
9.
go back to reference Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B (Methodological). 1995;57(1):289–300. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B (Methodological). 1995;57(1):289–300.
10.
11.
go back to reference Lindberg M, Ahlner J, Ekstrom T, Jonsson D, Moller M. Asthma nurse practice improves outcomes and reduces costs in primary health care. Scand J Caring Sci. 2002;16(1):73–8.CrossRefPubMed Lindberg M, Ahlner J, Ekstrom T, Jonsson D, Moller M. Asthma nurse practice improves outcomes and reduces costs in primary health care. Scand J Caring Sci. 2002;16(1):73–8.CrossRefPubMed
14.
go back to reference Holland W. Tackling assessment of the performance of health services. Eurohealth. 2007;13(4):1–3. Holland W. Tackling assessment of the performance of health services. Eurohealth. 2007;13(4):1–3.
15.
go back to reference Accordini S, Corsico AG, Braggion M, et al. The cost of persistent asthma in Europe: an international population-based study in adults. Int Arch Allergy Immunol. 2013;160(1):93–101.CrossRefPubMed Accordini S, Corsico AG, Braggion M, et al. The cost of persistent asthma in Europe: an international population-based study in adults. Int Arch Allergy Immunol. 2013;160(1):93–101.CrossRefPubMed
16.
go back to reference Cazzoletti L, Marcon A, Janson C, et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol. 2007;120(6):1360–7.CrossRefPubMed Cazzoletti L, Marcon A, Janson C, et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol. 2007;120(6):1360–7.CrossRefPubMed
17.
go back to reference Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13.CrossRefPubMedCentralPubMed Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13.CrossRefPubMedCentralPubMed
18.
go back to reference Vermeire PA, Rabe KF, Soriano JB, Maier WC. Asthma control and differences in management practices across seven European countries. Respir Med. 2002;96(3):142–9.CrossRefPubMed Vermeire PA, Rabe KF, Soriano JB, Maier WC. Asthma control and differences in management practices across seven European countries. Respir Med. 2002;96(3):142–9.CrossRefPubMed
Metadata
Title
Patient Reported Burden of Asthma on Resource Use and Productivity Across 11 Countries in Europe
Authors
Monica Fletcher
Ashok Jha
William Dunlop
Louise Heron
Verena Wolfram
Thys Van der Molen
David Price
Publication date
01-04-2015
Publisher
Springer Healthcare
Published in
Advances in Therapy / Issue 4/2015
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-015-0204-6

Other articles of this Issue 4/2015

Advances in Therapy 4/2015 Go to the issue